These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 29229282)

  • 1. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit.
    Sebire NJ; Foskett M; Short D; Savage P; Stewart W; Thomson M; Seckl MJ
    BJOG; 2007 Jun; 114(6):760-2. PubMed ID: 17516969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological diagnosis of hydatidiform mole: contemporary features and clinical implications.
    Sebire NJ
    Fetal Pediatr Pathol; 2010; 29(1):1-16. PubMed ID: 20055560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late spontaneous resolution of persistent molar pregnancy.
    Taylor F; Short D; Harvey R; Winter MC; Tidy J; Hancock BW; Savage PM; Sarwar N; Seckl MJ; Coleman RE
    BJOG; 2016 Jun; 123(7):1175-81. PubMed ID: 26774079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
    Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid progression from complete molar pregnancy to post-molar gestational trophoblastic neoplasia: a rare case report and literature review.
    Qian J; Gracious K; Sun L
    Front Oncol; 2023; 13():1303249. PubMed ID: 38162509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.